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Abstract The HOX genes are key determinants of cel-
lular identity both in early development and in the renewal
and differentiation of adult blood cells. Although a number
of studies have examined the expression of individual HOX
genes in defined blood cell lineages, we have undertaken a
comprehensive analysis of HOX gene expression in resting
and activated lymphocytic and monocytic subpopulations.
This has revealed distinct patterns of expression between
different cell types and resting and activated states. (Main
category A: Erythrocytes, Leukocytes and Hematopoiesis,
subcategory: 8: Lymphocytes).
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1 Introduction
The HOX genes are a family of homeodomain-containing
transcription factors that define specific positional identi-
ties, both in vertebrate and invertebrate embryos [4]. They
are also involved in the regulation of haemopoiesis
(reviewed by [13]), and blocking HOX gene function by the
use of antisense oligos or gene knock out perturbs a
number of different haemopoietic events. Thus for example
myeloid, erythroid and lymphoid haemopoiesis are all
defective in HoxA9 knock out mice [8], and the antisense
ablation of HoxB5, HoxB6, HoxB7 [15], or HoxA5 [5]
blocks erythroid differentiation. Forced expression of
HOXA10 in CD34+ progenitor cells purified from cord
blood results in a significant reduction in the number of B
cells and natural killer cells but a marked increase in
monocytes [14]. There are also examples of specific reg-
ulatory functions for HOX genes, including the modulation
of globin transcription by HOXB6 [12]. In addition, HOX
genes can also act to regulate the proliferation of haemo-
poietic stem cells (HSCs). Hence HOXB4 is a strong,
positive regulator of HSC self renewal (reviewed by [10]),
and an estrogen-dependant version of HOXB8 can be used
to drive the production of neutrophils and macrophages
from their respective progenitor cells [16].
Despite these studies, relatively little is still known
about the expression of HOX genes in the mature blood
lineages (reviewed by [6]). In order to address this we
purified different cell populations from human peripheral
blood on the basis of their expression of the surface
markers CD4, CD8, CD14 and CD19 that are present on T-
lymphocytes (CD4 and CD8), monocytes, and B-lympho-
cytes respectively. HOX expression was compared in
‘resting’ cells and cells that had been activated by chal-
lenging with specific antigenic stimuli—antibodies against
CD2, CD3 and CD28 for CD4+ and CD8+ cells, Lipo-
polysaccharide for CD14+ cells and anti-IgG for CD19+
cells. Each population of cells underwent proliferation in
response to this treatment, as measured by [3H]thymidine
incorporation (Fig. 1). RNA was extracted from each cell
type and the expression of each of the 39 HOX genes was
assed by quantitative PCR (QPCR), relative to the amount
of Beta-actin transcript present (Fig. 2).
The highest level of expression is generally shown by
the HOXA and HOXC genes, with HOXD genes generally
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exhibiting a tenfold lower expression level and HOXB
genes a 100 fold lower expression level, a feature that is
also true for the other cell populations examined. For all of
the HOX genes expressed in CD4+ cells there is a signif-
icant reduction in HOX expression upon activation. This is
particularly striking for the most posterior genes of the
HOXA, HOXC and HOXD clusters. A similar pattern is also
observed in CD8+ cells, although there is a general
reduction in HOX expression with every HOX gene except
HOXC10 being present at lower levels in these cells.
There are a number of notable differences between the
HOX expression profile of CD14+ cells and the CD4+/CD8+
populations. HOXC4, HOXC6 and HOXC8 are not expres-
sed. The most striking difference though is the change of
HOX expression upon activation—in contrast to CD4+/
CD8+ cells, CD14+ cells show a large increase in HOXA2,
HOXB13, HOXC10, HOXC13, HOXD1 and HOXD9. Other
HOX genes such as HOXB4 and HOXA10 show no signifi-
cant change in expression upon activation, which again
contrasts with the response of CD4+/CD8+ cells.
CD19+ cells show a broadly similar pattern of HOX
expression to CD14+ cells prior to activation, but have a
distinct response to activation. Like CD4+/CD8+ cells,
CD19+ cells exhibit a large reduction in expression of most
HOX genes with the exception of HOXD10, HOXD11 and
HOXD12 that show a very strong increase in expression
upon activation.
To our knowledge this is the first comprehensive anal-
ysis of HOX gene expression in these leukocyte
populations. Taking the data as a whole, each population
shows a unique pattern of HOX expression that may define
cellular identity. Generally the expression levels are in
agreement with those previously reported for individual
HOX genes in other studies [6, 7, 9]. However the changes
of HOX gene expression upon cellular activation have not
previously been reported. The magnitude of these changes
is striking, with the activated T cell subsets exhibiting an
almost complete loss of expression of many HOX genes
especially the more posterior members of the groups
Fig. 1 Proliferation of activated lymphocyte populations. Prolifera-
tion was measured by [3H]thymidine incorporation 4 h after
activation. Values shown are the fold increase in incorporation
compared to resting cells. Error bars: SEM from triplicate
experiments
Fig. 2 HOX gene expression in resting (a) and activated (b) after
6 h, (c) after 24 h) lymphocytic and monocytic populations. Expres-
sion was assessed by quantitative PCR and is shown as a relative
value to the number of beta-actin transcripts (‘Relative expression’).
HOX genes are abbreviated to show only their family and paralogue
position, hence HOXA2 is shown as ‘A2’. HOX genes for which no
expression was detected are not shown in the figure. Each value
shown is the mean from three experiments. Significant changes in
expression levels (p \ 0.05) 6 and 24 h after activation are marked
(*). Error bars: SEM
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(HOXA10, HOXC13, and HOXD12). Conversely, activated
monocytic and B-lymphocyte cells show a large increase in
expression of the same genes. Given the key regulatory
roles of HOX genes it is likely that these changes in
expression facilitate the cellular changes associated with
activation. One of these is increased proliferation, a
response that is known to be mediated by HOX genes in a
number of hematopoietic lineages (reviewed by [1]).
Indeed the antisense mediated ablation of HOXB2 or
HOXB4 in T-lymphocytes was previously shown to block
the proliferation of activated cells (Care et al. 1995). Fur-
thermore HOXA10 deficiency causes a severe
immunological disturbance in uterine tissues characterised
by rapid T cell proliferation and a failure of progesterone-
mediated immunosuppression [17]. The HOX genes are
also likely to regulate lineage-specific transcription upon
Fig. 2 continued
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activation, and in this context the contrasting expression
levels of these genes presumably reflect the dramatically
different response of each cell type.
2 Materials and methods
CD4+, CD8+, CD14+ and CD19+ cells were isolated using
the Dynabead system (Invitrogen) and cultured as previ-
ously described [2]. Quantitative PCR was performed as
previously described [11]. [3H]thymidine incorporation
was evaluated by a standard procedure. Briefly, 2 lCi of
[3H]thymidine (20 Ci/mmol) was added for 4 h to each
well. Cells were then recovered, washed, and processed for
the determination of TCA precipitable radioactivity. Each
evaluation was performed in triplicate. T cell activation
was achieved using anti-CD2, anti-CD3 and anti-CD28
antibodies as supplied in the T cell activation/expansion kit
(Miltenyi Biotec).
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